Memantine Hydrochloride
- Product NDC
- 60505-6209
- 11-digit product format
- 605056209
- Labeler code
- 60505
- Product ID
- 60505-6209_6cfcef62-aadf-4c12-9fa7-2e8cb65f8d54
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- memantine hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Apotex Corp
- Application
- NDA022525
- Marketing category
- NDA
- Marketing start
- 2019-05-09
- Marketing end
- 0000-00-00
- Substance
- MEMANTINE HYDROCHLORIDE
- Active strength
- 14 mg/1
- Pharmacologic classes
- N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-6209-3 | 60505620903 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60505-6209-3) | 2019-05-09 | 0000-00-00 | No | No | Current |
| 60505-6209-9 | 60505620909 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60505-6209-9) | 2019-05-09 | 0000-00-00 | No | No | Current |